Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Hims & Hers Stock in Trouble?

TheMotleyFool

0 0

Hims & Hers Health (NYSE: HIMS) is a telehealth company that offers personalized solutions for its customers. And demand has been robust, with subscriptions for its products rising significantly in recent years.

While telehealth has for the most part not been a hot place to invest in, Hims & Hers Health has been the exception to that. Last year, its share price jumped by 172%. And this year, shares have already more than doubled in value (returns as of June 27).

Recently, however, its share price took a hit amid some troubling news involving Novo Nordisk (NYSE: NVO), the healthcare company behind popular diabetes and weight loss drugs Ozempic and Wegovy. And it raised questions about Hims & Hers' business practices.

Source Fool.com

Like: 0

HIMS

Share